Inactive Instrument

Pymepharco Joint Stock Company

Equities

PME

VN000000PME9

STADA Arzneimittel Aktiengesellschaft (DB:SAZ) acquired an unknown minority stake in Pymepharco Joint Stock Company.

December 05, 2018

STADA Arzneimittel Aktiengesellschaft (DB:SAZ) acquired an unknown minority stake in Pymepharco Joint Stock Company (HOSE:PME) on December 6, 2018. Post the transaction, STADA indirectly holds 72% stake in Pymepharco. STADA Arzneimittel Aktiengesellschaft (DB:SAZ) completed the acquisition of an unknown minority stake in Pymepharco Joint Stock Company (HOSE:PME) on December 6, 2018.

Latest news about Pymepharco Joint Stock Company

Pymepharco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-20	CI
Pymepharco Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI
Pymepharco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-19	CI
Pymepharco Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-20	CI
Pymepharco Joint Stock Company Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-20	CI
Pymepharco Joint Stock Company Announces Executive Changes	20-05-13	CI
Pymepharco Joint Stock Company Announces Earnings Results for the Year 2019; Provides Earnings Guidance for 2020	20-05-13	CI
Pymepharco Joint Stock Company Announces Cash Dividend for 2019, Payable on June 02, 2020	20-05-08	CI
Pymepharco Joint Stock Company Announces Resignation of Mark Burgess Keatley as Member of BOD	20-03-11	CI
Pymepharco Joint Stock Company to Set Up a New Branch	20-02-05	CI
Pymepharco Joint Stock Company to Pay First Cash Dividend, Payable on March 2020	19-12-03	CI
Pymepharco Joint Stock Company Announces Resignation of Ludwig Otto Friedrich Klöter from Deputy CEO from April 22, 2019	19-04-16	CI
STADA Arzneimittel Aktiengesellschaft (DB:SAZ) acquired an unknown minority stake in Pymepharco Joint Stock Company.	18-12-05	CI
Pymepharco Joint Stock Company Announces Second Cash Dividend for 2017, Payable on May 31, 2018	18-05-11	CI
Pymepharco Joint Stock Company Announces Audited Earnings Results for the Year 2017; Provides Earnings Guidance for the Year 2018	18-05-10	CI
Pymepharco Joint Stock Company Announces First Phase of Cash Dividend of 2017	18-03-15	CI

Chart Pymepharco Joint Stock Company

Duration

Period

More charts

Company Profile

Pymepharco Joint Stock Company is a Vietnam-based company primarily engaged in the Pharmaceutical sector. The Company manufactures and distributes pharmaceuticals, medicinal products and materials. Its product line includes antibiotics, analgesics, antipyretics, anti-inflammatory, anti-rheumatic, anti-bacterial combinations, vitamins and minerals. The Company produces medicines in various forms, comprising tablet, soft capsule, hard capsule, granule and liquid.

Sector

More about the company